View of Cardiovascular Outcomes of Glp-1 Receptor Agonists and Sglt2 Inhibitors in Patients with Coronary Artery Disease: A Study with Emphasis on Overweight and Obesity

Return to Issue Details Cardiovascular Outcomes of Glp-1 Receptor Agonists and Sglt2 Inhibitors in Patients with Coronary Artery Disease: A Study with Emphasis on Overweight and Obesity Download Download PDF